RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.

Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.

Updates are delayed or unverified. Check original sources for the latest information.

Your saved research and appointment questions

View recorded trial and retraction changes

ICD Q61.2ORPHA:730ADPKD

Autosomal Dominant Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, causing fluid-filled cysts to grow in the kidneys over decades and often leading to kidney failure. It affects approximately 25,000 Australians. The first disease-modifying treatment (tolvaptan) is now available, and research into additional therapies is progressing rapidly.

This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.

1,005
Articles
88
Trials (9 AU)
Data refreshed
25 September 2026
Loading...

Common Questions

What is Autosomal Dominant Polycystic Kidney Disease?

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, causing fluid-filled cysts to grow in the kidneys over decades and often leading to kidney failure. It affects approximately 25,000 Australians. The first disease-modifying treatment (tolvaptan) is now available, and research into additional therapies is progressing rapidly.

How many clinical trials are available for Autosomal Dominant Polycystic Kidney Disease?

RareWays currently indexes 88 clinical trials for Autosomal Dominant Polycystic Kidney Disease, of which 14 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.

Where does the research data for Autosomal Dominant Polycystic Kidney Disease come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Autosomal Dominant Polycystic Kidney Disease.

Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.